We performed validation in both bladder cancer and renal cancer cell lines and similarly found that CD276 expression in tumor cells was significantly higher than in normal urothelial cells and renal tubular epithelial cells (Figure 1E). This evidence concerns the gene CD276 and renal carcinoma.